Soofi A, Li V, Beamish J, Abdrabh S, Hamad M, Das N
Am J Physiol Renal Physiol. 2023; 326(2):F178-F188.
PMID: 37994409
PMC: 11198972.
DOI: 10.1152/ajprenal.00184.2023.
Kontoghiorghes G
Int J Mol Sci. 2023; 24(16).
PMID: 37629109
PMC: 10454416.
DOI: 10.3390/ijms241612928.
Sun X, Huang N, Li P, Dong X, Yang J, Zhang X
Life Sci. 2023; 321:121608.
PMID: 36958437
PMC: 11483487.
DOI: 10.1016/j.lfs.2023.121608.
Aggarwal A, Dinda A, Mukhopadhyay C
ACS Omega. 2022; 7(32):27804-27817.
PMID: 35990481
PMC: 9386824.
DOI: 10.1021/acsomega.1c06716.
Gutierrez O
Kidney Int Rep. 2021; 6(9):2261-2269.
PMID: 34514189
PMC: 8418942.
DOI: 10.1016/j.ekir.2021.05.020.
Iron deficiency exacerbates cisplatin- or rhabdomyolysis-induced acute kidney injury through promoting iron-catalyzed oxidative damage.
Zhao S, Wang X, Zheng X, Liang X, Wang Z, Zhang J
Free Radic Biol Med. 2021; 173:81-96.
PMID: 34298093
PMC: 9482792.
DOI: 10.1016/j.freeradbiomed.2021.07.025.
Acute Kidney Injury following Cardiopulmonary Bypass: A Challenging Picture.
Liu D, Liu B, Liang Z, Yang Z, Ma F, Yang Y
Oxid Med Cell Longev. 2021; 2021:8873581.
PMID: 33763177
PMC: 7963912.
DOI: 10.1155/2021/8873581.
Ferrotoxicity and Its Amelioration by Calcitriol in Cultured Renal Cells.
Annamalai C, Seth R, Viswanathan P
Anal Cell Pathol (Amst). 2021; 2021:6634429.
PMID: 33680716
PMC: 7925041.
DOI: 10.1155/2021/6634429.
Ferrotoxicity and its amelioration by endogenous vitamin D in experimental acute kidney injury.
Annamalai C, Ganesh R, Viswanathan P
Exp Biol Med (Maywood). 2020; 245(16):1474-1489.
PMID: 32741217
PMC: 7553091.
DOI: 10.1177/1535370220946271.
Association Between Iron Status and Risk of Chronic Kidney Disease in Chinese Adults.
Zhu Y, Liu X, Li N, Cui L, Zhang X, Liu X
Front Med (Lausanne). 2020; 6:303.
PMID: 31998726
PMC: 6961557.
DOI: 10.3389/fmed.2019.00303.
Iron Chelation as a Potential Therapeutic Strategy for AKI Prevention.
Sharma S, Leaf D
J Am Soc Nephrol. 2019; 30(11):2060-2071.
PMID: 31554656
PMC: 6830795.
DOI: 10.1681/ASN.2019060595.
Parenteral versus oral iron therapy for adults and children with chronic kidney disease.
OLone E, Hodson E, Nistor I, Bolignano D, Webster A, Craig J
Cochrane Database Syst Rev. 2019; 2:CD007857.
PMID: 30790278
PMC: 6384096.
DOI: 10.1002/14651858.CD007857.pub3.
Protective Role of Histidine Supplementation Against Oxidative Stress Damage in the Management of Anemia of Chronic Kidney Disease.
Vera-Aviles M, Vantana E, Kardinasari E, Koh N, Latunde-Dada G
Pharmaceuticals (Basel). 2018; 11(4).
PMID: 30347874
PMC: 6315830.
DOI: 10.3390/ph11040111.
Iron Homeostasis Pathways as Therapeutic Targets in Acute Kidney Injury.
Swaminathan S
Nephron. 2018; 140(2):156-159.
PMID: 29982259
PMC: 6165684.
DOI: 10.1159/000490808.
Catalytic iron and acute kidney injury.
Leaf D, Swinkels D
Am J Physiol Renal Physiol. 2016; 311(5):F871-F876.
PMID: 27534995
PMC: 5130458.
DOI: 10.1152/ajprenal.00388.2016.
Plasma Prostaglandin E2 Levels Correlated with the Prevention of Intravenous Immunoglobulin Resistance and Coronary Artery Lesions Formation via CD40L in Kawasaki Disease.
Kuo H, Wang C, Yang K, Lo M, Hsieh K, Li S
PLoS One. 2016; 11(8):e0161265.
PMID: 27525421
PMC: 4985059.
DOI: 10.1371/journal.pone.0161265.
Lipocalin 2 alleviates iron toxicity by facilitating hypoferremia of inflammation and limiting catalytic iron generation.
Xiao X, Yeoh B, Saha P, Aguilera Olvera R, Singh V, Vijay-Kumar M
Biometals. 2016; 29(3):451-65.
PMID: 27007712
PMC: 4880510.
DOI: 10.1007/s10534-016-9925-5.
Renal iron overload in rats with diabetic nephropathy.
Dominguez J, Liu Y, Kelly K
Physiol Rep. 2015; 3(12).
PMID: 26702071
PMC: 4760458.
DOI: 10.14814/phy2.12654.
Fibroblast growth factor 23 and acute kidney injury.
Neyra J, Moe O, Hu M
Pediatr Nephrol. 2014; 30(11):1909-18.
PMID: 25480729
PMC: 4458234.
DOI: 10.1007/s00467-014-3006-1.
Plasma catalytic iron, AKI, and death among critically ill patients.
Leaf D, Rajapurkar M, Lele S, Mukhopadhyay B, Waikar S
Clin J Am Soc Nephrol. 2014; 9(11):1849-56.
PMID: 25189925
PMC: 4220757.
DOI: 10.2215/CJN.02840314.
